Dr John Charles Luke, MD | |
177 Main St, Suite 206, Huntington, NY 11743-6917 | |
(631) 271-5155 | |
(631) 544-9215 |
Full Name | Dr John Charles Luke |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 177 Main St, Huntington, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215035704 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 131134 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Charles Luke, MD 177 Main St, Suite 206, Huntington, NY 11743-6917 Ph: (631) 271-5155 | Dr John Charles Luke, MD 177 Main St, Suite 206, Huntington, NY 11743-6917 Ph: (631) 271-5155 |
News Archive
Health experts have warned for years that men and women with excess abdominal fat run a greater risk of developing cardiovascular problems.
Using mouse models, scientists have investigated the active plasma metabolite of remdesivir, GS-441 524, and hydroxychloroquine as possible drug candidates in COVID-19. The research shows GS-441 524 could be an effective therapeutic drug against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while at the same time discounting hydroxychloroquine as a reliable anti-viral.
The most comprehensive assessment to date of global adult mortality appears today, April 30, in The Lancet . The study, "Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis", shows that across countries, inequality in adult mortality has grown to the point where adult men in Swaziland - the country with the worst mortality rate - now have a probability of premature death that is nine times the mortality rate of the best country, Cyprus.
Positron Corporation a molecular imaging company announced today that it is developing indium oxine, a radiopharmaceutical widely used for the radiolabeling of blood elements. This project signifies Positron's entrance into direct radiopharmaceutical manufacturing and sales; indium oxine is the first new product in development at Positron's research, development and manufacturing facility in Crown Point, Indiana.
The Johns Hopkins Bloomberg School of Public Health has been awarded $18.4 million by the Orthopaedic Extremity Trauma Research Program (OETRP) of the U.S. Department of Defense to establish an Extremity Trauma Clinical Research Consortium.
› Verified 5 days ago
Dr. Jonathan Sarezky, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 755 New York Ave Ste 309, Huntington, NY 11743 Phone: 631-351-1250 | |
Dr. Juliana Kanji, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 775 Park Ave, Suite 154, Huntington, NY 11743 Phone: 631-427-1100 Fax: 631-784-7748 | |
Veena Kulkarni, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 55 Horizon Dr, Huntington, NY 11743 Phone: 631-920-8088 | |
Dr. Nina Nasreen Greif, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 120 New York Ave, Ste 6w, Huntington, NY 11743 Phone: 516-578-6104 | |
Raghu Mitra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 55 Horizon Dr, Huntington, NY 11743 Phone: 631-920-8000 | |
Dr. Frantz Narhum Moise, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 775 Park Ave, Ste 200-11, Huntington, NY 11743 Phone: 631-425-0277 Fax: 631-784-7705 | |
Dr. Liat J Jarkon, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 151 W Carver St, Huntington, NY 11743 Phone: 631-271-1988 Fax: 631-659-3255 |